Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ampio Appoints Chief Financial Officer | Contract Pharma

What are you searching for?

Sign in

Ampio Appoints Chief Financial Officer

Dan Stokely brings more than 30 years of experience in finance and accounting

By: Cassandra Gervolino

Ampio Pharmaceuticals, Inc. has appointed Dan Stokely as Chief Financial Officer.
 
Mr. Stokely has more than 30 years of experience in finance and accounting and is a Certified Public Accountant. Dan has spent the majority of his career in positions of financial leadership within both publicly traded and privately-held pharmaceutical companies. Since 2012, Dan served as Executive Vice President and Chief Financial Officer of Sentynl Therapeutics as well as Vice President of Finance and Chief Accounting Officer of Victory Pharma. 
 
Michael Macaluso, Ampio CEO, noted, “As we are already dosing patients in our pivotal Phase III trial of Ampion, as a biological treatment for adults with pain due to severe osteoarthritis of the knee (OAK), we sought a seasoned CFO with the experience and skills to advise us as we continue to move toward a future commercialization of Ampion.” 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters